Drug reference

Morphine with cyclizine

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 508, 509

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

CYCLIMORPH-10 ® Moderate to severe pain (short-term use only) ▶BY SUBCUTANEOUS INJECTION, OR BY INTRAMUSCULAR INJECTION, OR BY INTRAVENOUS INJECTION ▶Adult: 1 mL, do not repeat dose more often than every 4 hours; maximum 3 doses per day CYCLIMORPH-15 ® Moderate to severe pain (short-term use only) ▶BY SUBCUTANEOUS INJECTION, OR BY INTRAMUSCULAR INJECTION, OR BY INTRAVENOUS INJECTION ▶Adult: 1 mL, do not repeat dose more often than every 4 hours; maximum 3 doses per day

PDF page 508

Cautions

Myocardial infarction (cyclizine may aggravate severe heart failure and counteract the haemodynamic beneﬁts of opioids). not recommended in palliative care

PDF page 508

Safety

Interactions

→Appendix 1: antihistamines, sedating. opioids

PDF page 508

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Cyclimorph (Advanz Pharma) Morphine tartrate 15 mg per 1 ml, Cyclizine tartrate 50 mg per 1 ml Cyclimorph 15 solution for injection 1ml ampoules | 5 ampoule P £9.12 DT = £9.12 b Morphine tartrate 10 mg per 1 ml, Cyclizine tartrate 50 mg per 1 ml Cyclimorph 10 solution for injection 1ml ampoules | 5 ampoule P £8.77 DT = £8.77 b eiiii F 467

PDF page 509

Dose text by age group

Adult

1 mL, do not repeat dose more often than every

First-line fragment. Read the complete Indications and Dose section above.

PDF page 508

Adult

1 mL, do not repeat dose more often than every

First-line fragment. Read the complete Indications and Dose section above.

PDF page 508

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Morphine with cyclizine

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 508, 509

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

PDF page 508

Cautions

Myocardial infarction (cyclizine may aggravate severe heart failure and counteract the haemodynamic beneﬁts of opioids). not recommended in palliative care

PDF page 508

Safety

Interactions

→Appendix 1: antihistamines, sedating. opioids

PDF page 508

Dose and formulations

Medicinal Forms

PDF page 509

Dose text by age group

Adult

1 mL, do not repeat dose more often than every

First-line fragment. Read the complete Indications and Dose section above.

PDF page 508

Adult

1 mL, do not repeat dose more often than every

First-line fragment. Read the complete Indications and Dose section above.

PDF page 508

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.